Akèy › Maladi Greff-versus-host › Kansas
Etid klinik pou Maladi Greff-versus-host nan Kansas
3 etid pou Maladi Greff-versus-host ap chèche patisipan nan sit nan Kansas.
Tèks ofisyèl etid la (Anglè)
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- University of Kansas Hospital Authority, Kansas City
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou May 20, 2026 · NCT06615050Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
- University of Kansas Cancer Center, Westwood
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Mar 25, 2026 · NCT03533816A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- University of Kansas Cancer Center-Westwood, Westwood
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Dec 15, 2025 · NCT06619561Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.